The DOI matches its Crossref record; 292 of the 292 references it cites were found in a registry or an index.
The G protein-coupled oestrogen receptor GPER in health and disease: an update
Open accessAbstract
Oestrogens and their receptors contribute broadly to physiology and diseases. In premenopausal women, endogenous oestrogens protect against cardiovascular, metabolic and neurological diseases and are involved in hormone-sensitive cancers such as breast cancer. Oestrogens and oestrogen mimetics mediate their effects via the cytosolic and nuclear receptors oestrogen receptor-α (ERα) and oestrogen receptor-β (ERβ) and membrane subpopulations as well as the 7-transmembrane G protein-coupled oestrogen receptor (GPER). GPER, which dates back more than 450 million years in evolution, mediates both rapid signalling and transcriptional regulation. Oestrogen mimetics (such as phytooestrogens and xenooestrogens including endocrine disruptors) and licensed drugs such as selective oestrogen receptor modulators (SERMs) and downregulators (SERDs) also modulate oestrogen receptor activity in both health and disease. Following up on our previous Review of 2011, we herein summarize the progress made in the field of GPER research over the past decade. We will review molecular, cellular and pharmacological aspects of GPER signalling and function, its contribution to physiology, health and disease, and the potential of GPER to serve as a therapeutic target and prognostic indicator of numerous diseases. We also discuss the first clinical trial evaluating a GPER-selective drug and the opportunity of repurposing licensed drugs for the targeting of GPER in clinical medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both PLCD3 and SLC22A5 are associated with estrogen‐related signaling pathways (Figure S5), with PLCD3 being a phospholipase C (PLC) isozyme activated by G protein‐coupled estrogen receptor (GPER) 60 , 61 and SLC22A5 being a carnitine transport protein transcriptionally regulated by estrogen receptors. 62”
From Unraveling sex differences in Alzheimer's disease and related endophenotypes with brain proteomes (2025) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both PLCD3 and SLC22A5 are associated with estrogen‐related signaling pathways (Figure S5), with PLCD3 being a phospholipase C (PLC) isozyme activated by G protein‐coupled estrogen receptor (GPER) 60 , 61 and SLC22A5 being a carnitine transport protein transcriptionally regulated by estrogen receptors. 62”
From Unraveling sex differences in Alzheimer's disease and related endophenotypes with brain proteomes (2025) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PLCD3 is a phospholipase C (PLC) isozyme activated by G protein‐coupled estrogen receptor (GPER) and is involved in phosphoinositide turnover and protein kinase C (PKC) activation. 60 , 61”
From Unraveling sex differences in Alzheimer's disease and related endophenotypes with brain proteomes (2025) · cites this paper as [61]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–292 of 292
Zhang, H., Lu, S., Xu, R., Tang, Y., Liu, J., Li, C., Wei, J., Yao, R., Zhao, X., Wei, Q., et al. (2020) · Endocrinology · doi:10.1210/endocr/bqaa190 · Cited by 43
Wang, H. H., de Bari, O., Arnatt, C. K., Liu, M., Portincasa, P., & Wang, D. Q. ‐. (2020) · Hepatology · doi:10.1002/hep.31212 · Cited by 43
GPER agonist dilates mesenteric arteries via PI3K-Akt-eNOS and potassium channels in both sexes
Peixoto, P., Aires, R. D., Lemos, V. S., Bissoli, N. S., & dos Santos, R. L. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.06.020 · Cited by 42
Lu, A. S., Rouhimoghadam, M., Arnatt, C. K., Filardo, E. J., & Salem, A. K. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00018 · Cited by 40
Next-Generation Endocrine Therapies for Breast Cancer
McDonnell, D. P., Wardell, S. E., Chang, C., & Norris, J. D. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.03565 · Cited by 40
Improving clinical outcomes through attention to sex and hormones in research
Mielke, M. M., & Miller, V. M. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00531-z · Cited by 40
Chang, Y.-C., Han, Z., Zhang, Y., Zhou, Y., Feng, Z., Chen, L., Li, X., Li, L., & Si, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108666 · Cited by 40
Pang, Y., & Thomas, P. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.06.014 · Cited by 40
Itoga, M., Konno, Y., Moritoki, Y., Saito, Y., Ito, W., Tamaki, M., Kobayashi, Y., Kayaba, H., Kikuchi, Y., Chihara, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123210 · Cited by 39
G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity
Meyer, M. R., Fredette, N. C., Barton, M., & Prossnitz, E. R. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0257 · Cited by 39
Self-citationQin, B. Y., Dong, L., Guo, X., Jiang, J., He, Y.-X., Wang, X., Li, L., & Zhao, J. (2014) · PubMed Central · Cited by 38
Activation of GPER ameliorates experimental pulmonary hypertension in male rats
Alencar, A. K. N., Montes, G. C., Montagnoli, T. L., Silva, A. M., Martinez, S. T., Fraga, A. G. M., Wang, H., Groban, L., Sudo, R. T., & Zapata‐Sudo, G. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.11.009 · Cited by 38
GPER-Deficient Rats Exhibit Lower Serum Corticosterone Level and Increased Anxiety-Like Behavior
Zheng, Y., Wu, M., Gao, T., Li, M., Ding, X., Meng, Y., Jiao, Y., Luo, P., He, Z., Sun, T., et al. (2020) · Neural Plasticity · doi:10.1155/2020/8866187 · Cited by 37
Molecular identification of bulbospinal ON neurons by GPER, which drives pain and morphine tolerance
Jiao, Y., Gao, P., Li, D., Ding, X., Meng, Y., Qian, J., Gao, T., Wang, R., Jiang, T., Zhang, Y., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154588 · Cited by 37
Li, Y., Chen, Y., Zhu-xia, Z., Liu, X., Yang, L., Wan, L., Lei, T., & Wang, X. (2013) · Toxicology · doi:10.1016/j.tox.2013.04.012 · Cited by 36
Li, Y., Ding, X., Li, H., & Zhang, C. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12143 · Cited by 36
Seifert, H. A., Benedek, G., Nguyen, H., Kent, G., Vandenbark, A. A., & Offner, H. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0063-8 · Cited by 36
Han, Z., Chang, Y.-C., Zhou, Y., Zhang, H., Chen, L., Zhang, H., Si, J., & Li, L. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.251571 · Cited by 36
Lee, S., Kim, T. W., Park, G. L., Hwang, Y. S., Cho, H. J., Kim, J.-T., & Lee, H. G. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.11.007 · Cited by 35
A Series of Indole-Thiazole Derivatives Act as GPER Agonists and Inhibit Breast Cancer Cell Growth
O’Dea, A. T., Sondergard, C., Sweeney, P. R., & Arnatt, C. K. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00212 · Cited by 35
PERIPHERAL VASCULAR ACTION OF ESTROGEN IN THE HUMAN MALE 1
Reynolds, S. R. M., & Foster, F. I. (1939) · Journal of Clinical Investigation · doi:10.1172/jci101080 · Cited by 34
Tian, L., Shao, W., Ip, W., Song, Z., Badakhshi, Y., & Jin, T. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000444 · Cited by 34
Farruggio, S., Raina, G., Cocomazzi, G., Librasi, C., Mary, D., Gentilli, S., & Grossini, E. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4365 · Cited by 33
Chai, S., Liu, K., Feng, W., Liu, T., Wang, Q., Zhou, R., Chen, S., Wang, L., Chen, G., Ming, T., et al. (2019) · Clinical Science · doi:10.1042/cs20180919 · Cited by 32
Ribeiro, M. P. C., Santos, A. E., & Custódio, J. B. A. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.09.017 · Cited by 31
Role of estrogens in fish immunity with special emphasis on GPER1
Cabas, I., Chaves-Pozo, E., Mulero, V., & Ayala, A. G. (2018) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2018.08.001 · Cited by 31
GPER activation protects against epithelial barrier disruption by Staphylococcus aureus α-toxin
Triplett, K. D., Pokhrel, S., Castleman, M. J., Daly, S. M., Elmore, B. O., Joyner, J. A., Sharma, G., Herbert, G., Campen, M. J., Hathaway, H. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37951-3 · Cited by 31
Self-citationDinh, Q. N., Vinh, A., Kim, H. A., Saini, N., Broughton, B. R. S., Chrissobolis, S., Diep, H., Judkins, C. P., Drummond, G. R., & Sobey, C. G. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa075 · Cited by 31
Włodarczyk, M., Sobolewska-Włodarczyk, A., Cygankiewicz, A. I., Jacenik, D., Piechota-Polańczyk, A., & Stec‐Michalska, K. (2017) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.261.gpr · Cited by 31
NLRP3 inhibition improves heart function in GPER knockout mice
Wang, H., Sun, X., Hodge, H. S., Ferrario, C. M., & Groban, L. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.045 · Cited by 31
Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER
Gonçalves, G. K. N., Scalzo, S., Alves, A. P., Agero, U., Guatimosim, S., & dos Reis, A. M. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00060.2017 · Cited by 30
GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer
Cirillo, F., PELLEGRINO, M. A., Malivindi, R., Rago, V., Avino, S., Muto, L., Dolce, V., Vivacqua, A., Rigiracciolo, D. C., Marco, P. D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22541 · Cited by 30
Yu, X., Stallone, J. N., Heaps, C. L., & Han, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191418 · Cited by 30
Patkar, S., Farr, T. D., Cooper, E., Dowell, F. J., & Carswell, H. V. O. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.05.006 · Cited by 29
DeLeon, C., Wang, H. H., Gunn, J., Wilhelm, M., Cole, A., Arnett, S. D., Wang, D. Q. ‐., & Arnatt, C. K. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000592 · Cited by 29
Niro, S., Pereira, E., Pélissier, M. A., Morfin, R. F., & Hennebert, O. (2012) · Steroids · doi:10.1016/j.steroids.2012.01.019 · Cited by 28
Nox1 downregulators: A new class of therapeutics
Barton, M., Meyer, M. R., & Prossnitz, E. R. (2019) · Steroids · doi:10.1016/j.steroids.2019.108494 · Cited by 28
Self-citationWolfson, B., Padget, M. R., Schlom, J., & Hodge, J. W. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002258 · Cited by 28
Mercier, I. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00517-0 · Cited by 28
Kurt, A. H., Bozkuş, F., Üremiş, N., & Üremi̇ş, M. M. (2016) · Renal Failure · doi:10.3109/0886022x.2016.1155398 · Cited by 27
GPER blockers as Nox downregulators: A new drug class to target chronic non-communicable diseases
Meyer, M. R., & Barton, M. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.03.019 · Cited by 27
Self-citationCardioprotection Induced by Activation of GPER in Ovariectomized Rats With Pulmonary Hypertension
Alencar, A. K. N., Montes, G. C., Costa, D. G., Mendes, L. V. P., Silva, A. M. S., Martinez, S. T., Trachez, M. M., Cunha, V. D. M. N., Montagnoli, T. L., Fraga, A. G. M., et al. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly068 · Cited by 27
Why do women with melanoma do better than men?
Smalley, K. S. (2018) · eLife · doi:10.7554/elife.33511 · Cited by 27
17β-Estradiol inhibits cardiac fibroblast growth through both subtypes of estrogen receptor
Watanabe, T., Akishita, M., He, H., Miyahara, Y., Nagano, K., Nakaoka, T., Yamashita, N., Kozaki, K., & Ouchi, Y. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.232 · Cited by 27
Rapid actions of aldosterone revisited: Receptors in the limelight
Wehling, M. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.01.016 · Cited by 26
Tutzauer, J., de Valdivia, E. G., Swärd, K., Eilard, I. A., Broselid, S., Kahn, R., Olde, B., & Leeb-Lundberg, L. M. F. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000259 · Cited by 26
Wang, Q., Zhao, L., Liu, K., Liu, J., Chai, S., Chen, G., Wen, S., Ming, T., Wang, J., Ma, Y., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000216 · Cited by 26
Liu, Y., Du, F.-Y., Chen, W., Fu, P.-F., Yao, M., & Zheng, S.-S. (2015) · Europe PMC (PubMed Central) · Cited by 25
Aldosterone Stimulates Its Biosynthesis Via a Novel GPER-Mediated Mechanism
Caroccia, B., Seccia, T. M., Piazza, M., Prisco, S., Zanin, S., Iacobone, M., Lenzini, L., Pallafacchina, G., Domening, O., Poglitsch, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00043 · Cited by 24
Yue, J., Wang, X., Feng, B., Hu, L., Yang, L.-K., Lu, L., Zhang, K., Wang, Y., & Liu, S. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00287 · Cited by 24
27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer
Avena, P., Casaburi, I., Zavaglia, L., Nocito, M. C., Padula, D. L., Rago, V., Dong, J., Thomas, P., Mineo, C., Sirianni, R., et al. (2022) · Cancers · doi:10.3390/cancers14061521 · Cited by 24
Nicolaus Copernicus and the rapid vascular responses to aldosterone
Barton, M., & Meyer, M. R. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.05.005 · Cited by 24
Self-citationIgnatov, T., Treeck, O., Kalinski, T., Ortmann, O., & Ignatov, A. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05384-6 · Cited by 24
Amirkhosravi, L., Khaksari, M., Soltani, Z., Esmaeili‐Mahani, S., Karam, G. A., & Hoseini, M. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147168 · Cited by 23
Davis, G. K., Newsome, A. D., Cole, A. B., Ojeda, N. B., & Alexander, B. T. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12379 · Cited by 22
Yuan, L.-J., Wang, X., Wang, H.-T., Zhang, M., Sun, J., & Chen, W. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105384 · Cited by 22
Moriyama, M., Hashimoto, A., Satoh, H., Kawabe, K., Mizue, O., Takano, K., & Nakamura, Y. (2018) · International Journal of Inflammation · doi:10.1155/2018/8496973 · Cited by 21
Butler, M. J., Hildebrandt, R. P., & Eckel, L. A. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.05.018 · Cited by 21
Gohar, E. Y., Almutlaq, R. N., Daugherty, E. M., Butt, M. K., Jin, C., Pollock, J. S., Pollock, D. M., & Miguel, C. D. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00267.2020 · Cited by 21
A Conversation with Elwood Jensen
Moore, D. D. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153327 · Cited by 21
Evanson, K. W., Goldsmith, J. A., Ghosh, P., & Delp, M. D. (2018) · Pharmacology Research & Perspectives · doi:10.1002/prp2.409 · Cited by 21
Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics
Zheng, S., Yang, L., Dai, Y., Jiang, L., Wei, Y., Wen, H., & Xu, Y. (2019) · Journal of Computational Biology · doi:10.1089/cmb.2019.0119 · Cited by 21
Whitcomb, V., Wauson, E., Christian, D., Clayton, S., Giles, J. R., & Tran, Q. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113727 · Cited by 21
Yang, K., & Yao, Y. (2019) · PubMed Central · Cited by 20
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
Revankar, C. M., Bologa, C., Pepermans, R. A., Sharma, G., Petrie, W. K., Alcon, S. N., Field, A. S., Ramesh, C., Parker, M. A., Savchuk, N., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.10.009 · Cited by 20
Self-citationGPER Mediates Functional Endothelial Aging in Renal Arteries
Meyer, M. R., Rosemann, T. J., Barton, M., & Prossnitz, E. R. (2017) · Pharmacology · doi:10.1159/000478732 · Cited by 19
Self-citationWang, J., Li, H., Shen, S.-Y., Zhang, J., Liang, L., Huang, H., Li, B., Wu, G.-C., Zhang, Y., & Yu, J. M. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105807 · Cited by 19
Heart Failure With Preserved Ejection Fraction in Women
Barton, M., & Meyer, M. R. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.02.001 · Cited by 19
Self-citationContribution of GPR30 for 1,25 dihydroxyvitamin D3 protection in EAE
Subramanian, S., Miller, L., Grafe, M. R., Vandenbark, A. A., & Offner, H. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9266-6 · Cited by 18
Muller, C. Y., Chaney, M. F., Cohen, J. V., Garyantes, T. K., Lin, J. J., LoRusso, P. M., Mita, A. C., Mita, M. M., Natale, C. A., Orloff, M. M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.2022.40.16_suppl.2574 · Cited by 17
Gohar, E. Y., & Pollock, D. M. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000322 · Cited by 16
Estradiol mediates relaxation of porcine lower esophageal sphincter
Tsai, C., Tey, S., Chang, L.-C., Su, Y., Lin, K.-J., & Huang, S. (2018) · Steroids · doi:10.1016/j.steroids.2018.05.001 · Cited by 16
Muller, C. Y., Brown-Glaberman, U. A., Chaney, M. F., Garyantes, T. K., LoRusso, P. M., McQuade, J. L., Mita, A. C., Mita, M. M., Natale, C. A., Orloff, M. M., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.2021.39.15_suppl.3084 · Cited by 16
GPER is required for the age-dependent upregulation of the myocardial endothelin system
Meyer, M. R., Fredette, N. C., Sharma, G., Barton, M., & Prossnitz, E. R. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.041 · Cited by 15
Self-citationTHE CHEMICAL NATURE OF EMMENIN
Collip, J. B., Browne, J. S. L., & Thomson, D. L. (1934) · Endocrinology · doi:10.1210/endo-18-1-71 · Cited by 15
Sánchez, D. S., Sigel, L. K. F., Azurmendi, P. J., Vlachovsky, S. G., Oddo, E. M., Armando, I., Ibarra, F. R., & Silberstein, C. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.056 · Cited by 14
Costa, A. J., Lemes, R. M. R., Bartolomeo, C. S., Nunes, T. A., Pereira, G. C., Oliveira, R. B., Gomes, A. L., Smaili, S. S., Maciel, R. M. B., Newson, L. R., et al. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111775 · Cited by 14
de Souza, L. O., Machado, G. D. B., de Freitas, B. S., Rodrigues, S. L. C., Severo, M. P. A., Molz, P., da Silva, J. A. C., Bromberg, E., Roesler, R., & Schröder, N. (2021) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2021.107499 · Cited by 13
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia
Morelli, E., Hunter, Z. R., Fulciniti, M., Gullà, A., Perrotta, I. D., Zuccalà, V., Federico, C., Juli, G., Manzoni, M., Ronchetti, D., et al. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00305-x · Cited by 13
Zhu, L., Li, Q., Li, Q., Qi, D., Gao, C., & Yang, H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29427 · Cited by 13
Jafarynezhad, F., Shahbazian, M., Farhadi, Z., Yadeghari, M., Rezvani, M. E., Safari, F., & Azizian, H. (2022) · Intern J Endocrinol Metab · doi:10.5812/ijem-123560 · Cited by 11
Effects of certain 19-nor steroids on reproductive processes and fertility.
Pincus, G., Rock, J. A., Chang, M. C., & García, C.-R. (1959) · PubMed · Cited by 11
Shao, X., Li, J., Xu, F., Chen, D., & Liu, K. (2020) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2020/8811477 · Cited by 11
Urban, N. D., Leonhardt, M., & Schaefer, M. (2022) · Molecular Pharmacology · doi:10.1124/molpharm.122.000580 · Cited by 11
Fredette, N. C., Malik, E., Mukhtar, M., Prossnitz, E. R., & Terada, N. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00350.2019 · Cited by 10
Self-citationDawson, R. F., & Robson, J. M. (1939) · The Journal of Physiology · doi:10.1113/jphysiol.1939.sp003739 · Cited by 9
Zhou, C., Li, P., Han, M., & Gao, X. (2020) · Animal Biotechnology · doi:10.1080/10495398.2020.1842749 · Cited by 9
Stress-related arterial hypertension in Gper-deficient rats.
Luo, P., Wu, M., Gao, P., Gao, T., Li, D., Ding, X., Meng, Y., Qian, J., Zhang, G., & Rong, W. (2017) · PubMed · Cited by 8
Wang, D., Wang, M., Sun, P., & Gao, Q. (2021) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/133484 · Cited by 6
Jehle, J., Becher, U. M., Nöthel, M., Adler, S., Groll, K., Nickenig, G., & Tiyerili, V. (2021) · Archives of Medical Science · doi:10.5114/aoms/127200 · Cited by 3
Meyer, M. R., Daniel, C., Fredette, N. C., Amann, K., Barton, M., & Prossnitz, E. R. (2015) · Hypertension · doi:10.1161/hyp.66.suppl_1.p607 · Cited by 1
Self-citationMeyer, M. R., Daniel, C., Woods, C. D., Sharma, G., Fredette, N. C., Amann, K., Barton, M., & Prossnitz, E. R. (2018) · Hypertension · doi:10.1161/hyp.72.suppl_1.p261 · Cited by 1
Self-citation
Research works printed but not linked: 6
- Aristotélēs. Historia Animalium Books 1–10 (transl. and ed. Peck, A. L., Balme, D. M. & Gotthelf, A.) 1–624 (Harvard Univ. Press, 1965).
- Starling, E. H. Croonian lecture: on the chemical correlation of the functions of the body. Lancet 2, 579–583 (1905).
- Chourasia, T. K., Pang, Y. & Thomas, P. The catecholestrogen, 2-hydroxyestradiol-17beta, acts as a G protein-coupled estrogen receptor 1 (GPER/GPR30) antagonist to promote the resumption of meiosis in zebrafish oocytes. Biol. Reprod. 92(69), 1–13 (2015).
- Smith, H. O. et al. GPR30: a novel indicator of poor survival for endometrial carcinoma. Am. J. Obstet. Gynecol. 196 (386), e381–e389 (2007). This study was the first to suggest an association between GPER expression and clinical outcome and survival in patients with endometrial cancer.
- Carloni, E. L’azione degli estratti ovarici sull’atteggiamento dei capillari e sulla loro pressione, nelle varie fasi della rivoluzione funziozionale utero-ovarica. Arch. Ostet. Ginecol. 17, 327i (1930).
- Vance, D. A. Premarin: the intriguing history of a controversial drug. Int. J. Pharm. Compd. 1, 282–286 (2007).
Cited by
Sorted by citations
Hsu, S.-H., Chen, L.-R., & Chen, K.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212139 · Cited by 105
Identification, structure, and agonist design of an androgen membrane receptor
Yang, Z., Ping, Y.-Q., Wang, M., Zhang, C., Zhou, S., Xi, Y.-T., Zhu, K., Ding, W., Zhang, Q., Song, Z.-C., et al. (2025) · Cell · doi:10.1016/j.cell.2025.01.006 · Cited by 74
Kim, N., & Lukong, K. E. (2025) · Oncology Reviews · doi:10.3389/or.2025.1564642 · Cited by 73
Estrogen-immuno-neuromodulation disorders in menopausal depression
Zhang, Y., Tan, X., & Tang, C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03152-1 · Cited by 76
From physiology to pathology: Emerging roles of GPER in cardiovascular disease
Wang, Z., Liu, J., Chen, Y., Tang, Y., Chen, T., Zhou, C. S., Wang, S., Chang, R., Chen, Z., Yang, W., et al. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108801 · Cited by 57
Metadata
- Authors
- Prossnitz, E. R., & Barton, M.
- Affiliations
- University of New Mexico (US)
- University of Zurich (CH)
- Corresponding author
- Prossnitz, Eric R.
- Barton, Matthias
- Venue
- Nature Reviews Endocrinology
- Published
- 2023-05-16
- Volume
- 19
- Issue
- 7
- Pages
- 407-424
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- PMC
- PMC10187525
- OpenAlex
- W4376639723
- Cited by
- 231
- References
- 292
- Citations by year
- 2026: 63 · 2025: 91 · 2024: 68 · 2023: 9
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation
- Dialysis Clinics
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (122504, 108258)
- National Institutes of Health (CA118100, CA163890, GM121176)
- National Cancer Institute (R01CA127731, R01CA163890, P30CA118100, R01CA194496)
- National Institute of General Medical Sciences (P20GM121176)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Keywords
- endocrine disruptors, selective estrogen receptor modulators, estrogen receptor alpha, estrogen receptor beta, therapeutic target, drug repurposing
- MeSH terms
- Breast Neoplasms, Estrogens, Female, Humans, Receptors, Estrogen, GTP-Binding Proteins, Receptors, G-Protein-Coupled, Estrogen Receptor alpha, Estrogen Receptor beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review